Invictus Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 50.00 K
- Company Age 9 Year, 6 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 6.10 Cr
- Revenue Growth 169.07%
- Profit Growth 10.55%
- Ebitda 171.35%
- Total Assets 31.04%
About Invictus Pharma Llp
Invictus Pharma Llp (IPL) is 9 Year, 6 Days old Limited Liability Partnership 17 February 2016. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 50.00 K as per MCA.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAF-7351
- Incorporation Date
17 Feb 2016
- Date of Accounts and Solvency Statement
31 Mar 2022
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Invictus Pharma Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Patil  | Designated Partner | 17-Feb-2016 | Current |
| Pranal Shinde | Designated Partner | 17-Feb-2016 | Current |
Financial Performance of Invictus Pharma Llp.
Invictus Pharma Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 169.07% increase. The company also saw a substantial improvement in profitability, with a 10.55% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invictus Pharma Llp?
Unlock access to Invictus Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Goodman Vetcare Private LimitedVishal Patil and Pranal Shinde are mutual person
- Inovora Resources Private Limited
Vishal Patil is a mutual person
- Inovora Diagnostics Private Limited
Pranal Shinde is a mutual person
Charges (Loans)
₹61,010,000.00
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 6.00 Cr
- Axis Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2023 | Axis Bank Limited | ₹1.01 M | Open |
| 04 Feb 2023 | Icici Bank Limited | ₹6.00 Cr | Open |
How Many Employees Work at Invictus Pharma Llp?
Unlock and access historical data on people associated with Invictus Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invictus Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invictus Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.